Member-only story

HIV is CV: The Devastating Impact of CV on the HIV Population

Stan Ward

·5.8k Followers· Follow

Published in HIV Is CV Thomas Medonis

5 min read · 1 week before

371 View Claps

43 Respond

Save

Listen

Cardiovascular disease (CV) is the leading cause of death in the United States, and it is also a major cause of death in HIV-infected individuals. In fact, HIV-infected individuals are at a significantly increased risk for developing CV compared to the general population. This is due to a number of factors, including:

HIV Is CV

by Thomas Medonis

5 out of 5

Language	:	English
File size	:	476 KB
Text-to-Speech	:	Enabled
Screen Reader	:	Supported
Enhanced typesetting	:	Enabled
Word Wise	:	Enabled
Print length	:	5 pages

* The direct effects of HIV on the heart and blood vessels * The increased inflammation and immune activation associated with HIV infection * The use of certain antiretroviral medications * Other risk factors for CV, such as smoking, high blood pressure, and high cholesterol

Epidemiology

The prevalence of CV in HIV-infected individuals is estimated to be between 10% and 20%, which is significantly higher than the prevalence in the general population. This risk is even higher in certain groups of HIV-infected individuals, such as those who are older, have a longer duration of HIV infection, or have certain co-morbidities, such as diabetes or chronic kidney disease.

Pathophysiology

The exact mechanisms by which HIV infection leads to CV are not fully understood, but it is thought that a number of factors are involved. These factors include:

* The direct effects of HIV on the heart and blood vessels. HIV can damage the heart muscle, the blood vessels, and the lining of the heart. This damage can lead to a number of CV problems, including heart failure, coronary artery disease, and stroke. * The increased inflammation and immune activation associated with HIV infection. Inflammation is a normal response to infection, but it can become chronic in HIV-infected individuals. This chronic inflammation can damage the heart and blood vessels, and it can also lead to the formation of blood clots. * The use of certain antiretroviral medications. Some antiretroviral medications have been associated with an increased risk of CV. These medications include protease inhibitors and nucleoside reverse transcriptase inhibitors. * Other risk factors for CV, such as smoking, high blood pressure, and high cholesterol. HIV-infected individuals are more likely to have these other risk factors for CV, which can further increase their risk of developing CV.

Clinical Manifestations

The clinical manifestations of CV in HIV-infected individuals can vary depending on the type of CV problem. Some of the most common clinical manifestations include:

* Chest pain * Shortness of breath * Fatigue * Lightheadedness * Dizziness * Palpitations * Confusion * Loss of consciousness

Management

The management of CV in HIV-infected individuals is complex and requires a multidisciplinary approach. The goals of management are to:

* Reduce the risk of developing CV * Treat CV problems early and aggressively * Prevent complications of CV

There are a number of things that HIV-infected individuals can do to reduce their risk of developing CV, including:

* Quitting smoking * Controlling blood pressure * Managing cholesterol levels * Eating a healthy diet * Exercising regularly * Getting vaccinated against influenza and pneumonia

There are also a number of medications that can be used to treat CV in HIV-infected individuals. These medications include:

* Antiplatelet agents * Anticoagulants * Statins * Beta-blockers * ACE inhibitors * Angiotensin receptor blockers

In some cases, surgery may be necessary to treat CV in HIV-infected individuals.

CV is a major cause of death in HIV-infected individuals. The risk of developing CV is significantly higher in HIV-infected individuals than in the general population. This is due to a number of factors, including the direct effects of HIV on the heart and blood vessels, the increased inflammation and immune activation associated with HIV infection, the use of certain antiretroviral medications, and other risk factors for CV.

The management of CV in HIV-infected individuals is complex and requires a multidisciplinary approach. The goals of management are to reduce the risk of developing CV, treat CV problems early and aggressively, and prevent complications of CV.

HIV is CV is an essential resource for clinicians, researchers, and public health professionals working with this vulnerable population. This book provides a wealth of information on the epidemiology, pathophysiology, clinical manifestations, and management of CV in HIV-infected individuals.

HIV Is CV

by Thomas Medonis

5 out of 5